Recombinant Mouse IFN-gamma/IFNG protein (His Tag)

种属

Mouse

纯度

>90 %, SDS-PAGE

标签

His Tag

生物活性

未测试

Cat no : Eg0334

Print datasheet

Synonyms

IFN gamma, Ifng, IFN-gamma, Ifg, IFN g



产品信息

纯度 >90 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性 Not tested
来源 HEK293-derived Mouse IFN-gamma protein His23-Cys155 (Accession# P01580) with a His tag at the C-terminus.
基因ID 15978
蛋白编号 P01580
预测分子量 19.3 kDa
SDS-PAGE 20-35 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

The IFNs were originally discovered as agents that interfere with viral replication. Initially, they were classified by the secreting cell type but are now classified into type I and type II according to receptor specificity and sequence homology. Interferon gamma (IFN-γ) is a soluble cytokine that is the only member of the type II class of interferons. It is secreted by Th1 cells, cytotoxic T cells and NK cells. The cytokine is associated with antiviral, immunoregulatory and anti-tumor properties and is a potent activator of macrophages. It plays crucial roles in pathogen clearance. Aberrant Ifng expression is associated with a number of autoinflammatory and autoimmune diseases. It has been identified in many studies as a biomarker for pleural tuberculosis (TB). Mutations in this gene are associated with aplastic anemia.

参考文献:

1. Isaacs, A. et al.(1957). The interferon Proc. R. Soc. Lond. B Biol. Sci. 147: 258-267. 2. Gray PW. et al. (1982). Nature. 298 : 859-63. 3. Bullens, D. M. et al.(2001). Int. Immunol. 13: 181-191. 4. Wang Z. et al.(2014). Biosci Biotechnol Biochem.78: 588-92. 5. Chegou NN. et al.(2012). PLoS One.7(6):e38501